Neophore
Neophore is a biotechnology company that develops small molecule immuno-oncology therapeutics. Their compounds target components of the MMR pathway to enhance cancer neoantigen creation and stimulate immune responses in patients with specific cancer types.
- Drug discovery strategies
- Cancer neoantigen modulation
- Small molecule immuno-oncology therapeutics
Locations
Digital Popularity
Social Media
LinkedIn1,891 Followers
Company Details
Neophore is operated by Neophore Limited and is a Active company incorporated on 9 May 2017 with the registered office located in Altrincham, Greater Manchester. Neophore Limited was registered 8 years ago.
Status
Active
Size
Micro
Directors
10
Age
8 years old
Employees
10
Turnover
Unreported
Total Assets
£10.61M
Cash in Bank
£9.11M
Total Liabilities
-£1.47M
Teams
12
5
3
5
Chief Executive Officer • Joined Jan 2020
Executive Assistant To CEO, CFO & Executive Team • Joined Jul 2021
Non Executive Director • Joined Mar 2021
Chief Scientific Officer • Joined Oct 2020
Chief Financial Officer • Joined Aug 2021
Principal Scientist - Biology • Joined Jun 2021
Principal Scientist - Immunology • Joined May 2021
Research Laboratory Manager • Joined Jan 2024
Director Of Biology • Joined Aug 2019
Biological Scientist • Joined Dec 2022
Chief Executive Officer • Joined Jan 2020
Non Executive Director • Joined Mar 2021
Chief Scientific Officer • Joined Oct 2020
Chief Financial Officer • Joined Aug 2021
Director Of Biology • Joined Aug 2019
Chief Scientific Officer • Joined Oct 2020
Research Laboratory Manager • Joined Jan 2024
Biological Scientist • Joined Dec 2022
Executive Assistant To CEO, CFO & Executive Team • Joined Jul 2021
Principal Scientist - Biology • Joined Jun 2021
Principal Scientist - Immunology • Joined May 2021
Scientist, Biology • Joined Nov 2024
Scientist, Biology • Joined Mar 2025
View 12 members